Blockchain Technology for Tracing Drug with a Multichain Platform: Simulation Method

Abstract

This study builds the implementation of the traceability process by conducting simulation tests using business process simulations with the implementation of blockchain technology to track drugs. This research focus involved stakeholders, including the pharmaceutical industry, pharmaceutical wholesalers (distributors/wholesalers), health services (drug stores, hospitals), consumers. Simulation methods are used to describe the distribution and traceability of drugs. Finally, the research contribution in incorporating blockchain technology to supply chain management could potentially help in drug traceability. This study provides an overview of blockchain technology capabilities to find out which stakeholders and assets are transacted on the blockchain system. A decentralized Autonomous Organization is an approach to organizing data on the blockchain that defines all stakeholders identities associated with different addresses. This process can organize each address's transactions on a special blockchain platform in this study using multichain. Furthermore, transactions that have occurred cannot be updated or deleted. This simulation also illustrates some of the blockchain characteristics that must exist, among others, transparent, distributed, immutable, and peer to peer transactions. This contribution gives supply chain management, in particular on drug distribution, stronger control over distribution.

A Systematic Literature Review of Blockchain-Enabled Supply Chain Traceability Implementations

“…This eliminates the possibility of fraud by a third party [80]. In [81] the authors apply simulation and blockchain technology to test the deployment of traceability processes in the pharmaceutical industry, especially drug traceability. The authors considered the entire pharmaceutical ecosystem, including the pharmaceutical industry, pharmaceutical wholesalers (distributors/wholesalers), health services (drug stores, hospitals), and consumers.…”